Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Nov 8:11:303.
doi: 10.3389/fnagi.2019.00303. eCollection 2019.

Parkinson's Disease-Mild Cognitive Impairment (PD-MCI): A Useful Summary of Update Knowledge

Davide Maria Cammisuli  1 , Salvatore Massimiliano Cammisuli  2 , Jonathan Fusi  3 , Ferdinando Franzoni  3 , Carlo Pruneti  1
Affiliations

Parkinson's Disease-Mild Cognitive Impairment (PD-MCI): A Useful Summary of Update Knowledge

Davide Maria Cammisuli et al. Front Aging Neurosci. .

Abstract

Mild cognitive impairment (MCI) is a common feature in Parkinson's Disease (PD), even at the time of diagnosis. Some levels of heterogeneity in nature and severity of cognitive impairment and risk of conversion to Parkinson's Disease Dementia (PDD) exist. This brief overview summarized the current understanding of MCI in PD, by considering the following major points: historical development of the clinical entity, evaluation, epidemiology, predictors and outcomes, neuroimaging findings, pathophysiology, treatment, and pharmacological and non-pharmacological intervention. MCI in PD represents a concept in evolution and plays a pivotal role in advancing our understanding of the disease mechanisms, with the ultimate goal of building effective strategies to prevent conversion into PDD. Challenges for future research are also discussed.

Keywords: PD-MCI; biomarkers; epidemiology; pathophysiology; treatment.

PubMed Disclaimer

References

    1. Adenzato M., Manenti R., Enrici I., Gobbi E., Brambilla M., Alberici A., et al. . (2019). Transcranial direct current stimulation enhances theory of mind in Parkinson’s disease patients with mild cognitive impairment: a randomized, double-blind, sham-controlled study. Transl. Neurodegener. 8:1. 10.1186/s40035-018-0141-9 - DOI - PMC - PubMed
    1. Ahlskog J. E. (2011). Does vigorous exercise have a neuroprotective effect in Parkinson disease? Neurology 77, 288–294. 10.1212/WNL.0b013e318225ab66 - DOI - PMC - PubMed
    1. Albert M. S., DeKosky S. T., Dickson D., Dubois B., Feldman H. H., Fox N. C., et al. . (2011). The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the national institute on aging-Alzheimer’s association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 7, 270–279. 10.1016/j.jalz.2011.03.008 - DOI - PMC - PubMed
    1. Alonso-Frech F., Sanahuja J. J., Rodriguez A. M. (2011). Exercise and physical therapy in early management of parkinson disease. Neurologist 17, S47–S53. 10.1097/NRL.0b013e31823968ec - DOI - PubMed
    1. Alves G., Lange J., Blennow K., Zetterberg H., Andreasson U., Førland M. G., et al. . (2014). CSF Aβ42 predicts early-onset dementia in parkinson disease. Neurology 82, 1784–1790. 10.1212/WNL.0000000000000425 - DOI - PubMed

LinkOut - more resources